Hyperglycaemia, insulin therapy and critical penumbral regions for prognosis in acute stroke: further insights from the INSULINFARCT trial

Charlotte Rosso, Christine Pires, Jean-Christophe Corvol, Flore Baronnet, Sophie Crozier, Anne Leger, Sandrine Deltour, Romain Valabregue, Mélika Amor-Sahli, Stéphane Lehéricy, Didier Dormont, Yves Samson, Charlotte Rosso, Christine Pires, Jean-Christophe Corvol, Flore Baronnet, Sophie Crozier, Anne Leger, Sandrine Deltour, Romain Valabregue, Mélika Amor-Sahli, Stéphane Lehéricy, Didier Dormont, Yves Samson

Abstract

Background: Recently, the concept of 'clinically relevant penumbra' was defined as an area saved by arterial recanalization and correlated with stroke outcome. This clinically relevant penumbra was located in the subcortical structures, especially the periventricular white matter. Our aims were to confirm this hypothesis, to investigate the impact of admission hyperglycemia and of insulin treatment on the severity of ischemic damages in this area and to study the respective contributions of infarct volume and ischemic damage severity of the clinically relevant penumbra on 3-month outcome.

Methods: We included 99 patients from the INSULINFARCT trial. Voxel-Based Analysis was carried on the Apparent Diffusion Coefficient (ADC) maps obtained at day one to localize the regions, which were more damaged in patients i) with poor clinical outcomes at three months and ii) without arterial recanalization. We determined the intersection of the detected areas, which represents the clinically relevant penumbra and investigated whether hyperglycemic status and insulin regimen affected the severity of ischemic damages in this area. We performed logistic regression to examine the contribution of infarct volume or early ADC decrease in this strategic area on 3-month outcome.

Findings: Lower ADC values were found in the corona radiata in patients with poor prognosis (p< 0.0001) and in those without arterial recanalization (p< 0.0001). The tracking analysis showed that lesions in this area interrupted many important pathways. ADC values in this area were lower in hyperglycemic than in normoglycemic patients (average decrease of 41.6 ± 20.8 x10(-6) mm2/s) and unaffected by the insulin regimen (p: 0.10). ADC values in the clinically relevant penumbra, but not infarct volumes, were significant predictors of 3-month outcome.

Conclusion: These results confirm that the deep hemispheric white matter is part of the clinically relevant penumbra and show that hyperglycaemia exacerbates the apparition of irreversible ischemic damage within 24 hours in this area. However, early intensive insulin therapy fails to protect this area from infarction.

Trial registration: ClinicalTrials.gov NCT00472381.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Flow chart of the study.
Fig 1. Flow chart of the study.
CGT means Capillary glucose test. As pre-specified in the main protocol, patients for whom ore than 3 CGTs were missing during the treatment had to be excluded. VBA means voxel-based analysis and the VBA study refers to the study presented in this paper.
Fig 2. Region with lower ADC values…
Fig 2. Region with lower ADC values at day one in non-recanalized patients and in poor outcome patients.
A. Superposition of the area of day-one ADC decrease associated with 90-day poor outcome (in red) on ADC images (MNI space, z-coordinates). B. Superposition of the area of day-one ADC decrease associated with non-recanalized (vs. recanalized) patients (in blue) on ADC images (MNI space, z-coordinates). Images are shown using neuroradiological conventions (right hemisphere on the left side).
Fig 3. Tracking analysis from the strategic…
Fig 3. Tracking analysis from the strategic area.
Color code is directional (blue for z-axis, green for y-axis and red for x-axis). A. Superposition of the strategic area (in yellow) on a normalized ADC map. B Association and Projection tracts passing through the strategic area on a coronal view (left image) and on a sagittal view of a normalized ADC map. The color code is directional (pink for the x-axis, blue for z-axis and pink for y-axis). C. Association and Projection tracts travelling though the strategic area (in yellow). Left: The projections tract projections at the top in the following areas: primary motor, premotor, and parietal cortices (blue); Middle: The association tract passing through the yellow region contains part of the superior longitudinal fasciculus (green); Right: The fibers of the corpus callosum passing through the strategic area (pink).

References

    1. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40: 216–226.
    1. Moustafa RR, Baron JC. Pathophysiology of ischaemic stroke: insights from imaging, and implication for therapy and drug discovery. Br J Pharmacol. 2008;153 Suppl 1: S44–S54.
    1. Rosso C, Colliot O, Valabregue R, Crozier S, Dormont D, Lehéricy S, et al. Tissue-at-risk in the deep Middle Cerebral artery territory is critical for stroke outcome. Neuroradiology. 2011;53: 763–771. 10.1007/s00234-011-0916-5
    1. Rosso C, Samson Y. The ischemic penumbra: the location rather than the volume of recovery determines outcome. Curr Opin Neurol. 2014;27: 35–41. 10.1097/WCO.0000000000000047
    1. Buzsaki G. Structure defines Function Rhythms of the Brain. Oxford University Press: New York: 2006. p 29–61.
    1. Rosso C, Colliot O, Pires C, Delmaire C, Valabrègue R, Crozier S, et al. Early ADC changes in motor structures predict outcome of acute stroke better than lesion volume. J Neuroradiol. 2010;38: 105–112. 10.1016/j.neurad.2010.05.001
    1. Cuingnet R, Rosso C, Chupin M, Lehéricy S, Dormont D, Benali H, et al. Spatial regularization of SVM for the detection of diffusion alterations associated with stroke outcome. Med Image Anal. 2011;15: 729–737. 10.1016/j.media.2011.05.007
    1. Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S, et al. Intensive versus subcutaneous insulin in hyperacute stroke patients: Results from the randomised INSULINFARCT trial. Stroke. 2012;43: 2343–2349. 10.1161/STROKEAHA.112.657122
    1. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the NINDS rt-pa stroke trial. Neurology. 2002;59: 669–674.
    1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2011;32: 2426–2432.
    1. Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: Pathophysiology and clinical management. Nat Rev Neurol. 2010;6: 145–155. 10.1038/nrneurol.2009.231
    1. MacDougall NJ, Muir KW. Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: Systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31: 807–818. 10.1038/jcbfm.2010.210
    1. Tarr D, Graham D, Roy LA, Holmes WM, Mc Cabe C, Mhairi Macrae I, et al. Hyperglycaemia accelerates ADC-defined lesion growth after focal cerebral ischemia in rats with and without fetaure of metabolic syndromes. J Cereb Blood Flow Metab. 2013;33: 1556–1563. 10.1038/jcbfm.2013.107
    1. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34: 2208–2214.
    1. Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tpa. J Cereb Blood Flow Metab. 2007;27: 1616–1622.
    1. Rosso C, Attal Y, Deltour S, Hevia-Montiel N, Lehericy S, Crozier S, et al. Hyperglycemia and the fate of apparent diffusion coefficient-defined ischemic penumbra. AJNR Am J Neuroradiol. 2011;32: 852–856. 10.3174/ajnr.A2407
    1. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52: 20–28.
    1. Bellolio MF, Gilmore RM, Ganti L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev. 2014. 10.1002/14651858.CD005346.pub4
    1. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol. 2007;6: 397–406.
    1. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol. 2010;67: 570–578. 10.1002/ana.21983
    1. Fiebach JB, Jansen O, Schellinger PD, Heiland S, Hacke W, Sartor K. Serial analysis of the apparent diffusion coefficient time course in human stroke. Neuroradiology. 2002;44: 294–298.
    1. Fiehler J, Knab R, Reichenbach JR, Fitzek C, Weiller C, Röther J. Apparent diffusion coefficient decreases and magnetic resonance imaging perfusion parameters are associated in ische- mic tissue of acute stroke patients. J Cereb Blood Flow Metab. 2001;21: 577–584
    1. Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology. 1997;49: 113–119.
    1. Konrad, Vucurevic G, Musso F, Winterer G. VBM-DTI correlates of verbal intelligence: a potential link to Broca's area. J Cogn Neurosci. 2012;24: 888–895. 10.1162/jocn_a_00187
    1. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, Gass A, Nolte C, Kucinski T, et al.; Kompetenznetz Schlaganfall Study Group. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke. 2004;35: 109–14
    1. Vargas P, Gaudron M, Valabregue R, Bertasi E, Humbert F, Lehéricy S, et al. Assessment of corticospinal tract (CST) damage in acute stroke patients: comparison of tract-specific analysis versus segmentation of a CST template. J Magn Reson Imaging. 2013;37: 836–845. 10.1002/jmri.23870
    1. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage. 2005;25: 1325–1335.
    1. Phan TG, Chen J, Donnan G, Srikanth V, Wood A, Reutens DC. Development of a new tool to correlate stroke outcome with infarct topography: A proof-of-concept study. Neuroimage. 2010;49: 127–133. 10.1016/j.neuroimage.2009.07.067
    1. Puig J, Blasco G, Daunis-I-Estadella J, Thomalla G, Castellanos M, Figueras J, et al. Decreased corticospinal tract anisotropy predicts long term outcome after stroke. Stroke. 2013;44: 2016–2018. 10.1161/STROKEAHA.111.000382
    1. Nelles M, Gieseke J, Flacke S, Lachenmayer L, Schild HH, Urbach H. Diffusion Tensor Pyramidal tractography in atients with Anterior Choroidal Artery Infarcts. Am J Neuroradiol. 2008;29: 1708–1714. 10.3174/ajnr.A1201
    1. Catani M, Howard RJ, Pajevic S, Jones DK. Virtual in vivo interactive dissection of white matter fasciculi in the human brain. NeuroImage. 2002;17: 77–94.
    1. Martino J, De Lucas EM. Subcortical anatomy of the lateral association fascicles in the brain: A Review. Clin Anat. 2014;27: 563–569. 10.1002/ca.22321
    1. Makris N, Kennedy DN, McInerney S, Sorensen GA, Wang R, Caviness VS Jr, et al. (2005) Segmentation of subcomponents within the SLF in humans: A quantitative, in vivo, DT-MRI study. Cereb Cortex. 2005;15: 854–869
    1. Catani M, Dell’Acqua F, Bizzi A, Forkel SJ, Williams SC, Simmons A, et al. Beyond cortical localization in clinico-anatomical correlation. Cortex. 2012;48: 1262–1287 10.1016/j.cortex.2012.07.001
    1. Farr TD, Wegener S. Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence. J Cereb Blood Flow Metab. 2010;30: 703–717. 10.1038/jcbfm.2010.5
    1. Johnston KC, Wagner DP, Wang XQ, Newman GC, Thijs V, Sen S, et al.; GAIN, Citicoline, and ASAP Investigators. Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke. 2007;38: 1820–1825.
    1. Barber PA, Powers W. MR DWI does not substitute for stroke severity scores in predicting stroke outcome. Neurology. 2006;66: 1138–1139.
    1. Vogt G, Laage R, Shuaib A, Shneider A, VISTA Collaboration. Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: an analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke. 2012;43: 1266–1272. 10.1161/STROKEAHA.111.646570

Source: PubMed

3
Sottoscrivi